{"entity":{"type":"insider","cik":"0001464583","url":"/insider/0001464583","json_url":"/insider/0001464583.json","name":"Megna Michael R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":11,"first":"2023-12-21","last":"2026-04-13","span_basis":"filed_date"},"name_variants":[{"name":"Megna Michael R","source":"filing","n_filings":11,"first_seen":"2023-12-21","last_seen":"2026-04-13"}],"transactions":[{"id":5932526,"accession":"0001464583-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001464583-26-000006","line_url":"/filing/0001464583-26-000006#line-1","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6625.0,"shares_display":"6,625","price_per_share":46.69,"price_display":"46.69","price_state":"stated","total_value":309321.25,"total_display":"309,321.25","total_whole":"309,321","shares_owned_after":27418.0,"shares_owned_after_display":"27,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-09","filed_date":"2026-04-13","scope":"insider"},{"id":4151520,"accession":"0001464583-25-000005","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001464583-25-000005","line_url":"/filing/0001464583-25-000005","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50490.0,"shares_display":"50,490","price_per_share":38.87465735789265,"price_display":"38.87","price_state":"stated","total_value":1962781.45,"total_display":"1,962,781.45","total_whole":"1,962,781","shares_owned_after":40281.0,"shares_owned_after_display":"40,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-20","filed_date":"2025-10-22","scope":"insider","n_lines":2},{"id":4684478,"accession":"0001415889-25-023564","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-25-023564","line_url":"/filing/0001415889-25-023564#line-8","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":34.84,"price_display":"34.84","price_state":"stated","total_value":383240.0,"total_display":"383,240.00","total_whole":"383,240","shares_owned_after":38011.0,"shares_owned_after_display":"38,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-03","scope":"insider"},{"id":4434341,"accession":"0001415889-25-021177","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-021177","line_url":"/filing/0001415889-25-021177#line-3","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":32.35,"price_display":"32.35","price_state":"stated","total_value":549950.0,"total_display":"549,950.00","total_whole":"549,950","shares_owned_after":33041.0,"shares_owned_after_display":"33,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-04","filed_date":"2025-08-06","scope":"insider"},{"id":4501162,"accession":"0001415889-25-015782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-015782","line_url":"/filing/0001415889-25-015782#line-2","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15211.0,"shares_display":"15,211","price_per_share":28.75,"price_display":"28.75","price_state":"stated","total_value":437316.25,"total_display":"437,316.25","total_whole":"437,316","shares_owned_after":32546.0,"shares_owned_after_display":"32,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-05","scope":"insider"},{"id":4036381,"accession":"0001415889-25-012532","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-012532","line_url":"/filing/0001415889-25-012532#line-4","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17647.0,"shares_display":"17,647","price_per_share":26.69,"price_display":"26.69","price_state":"stated","total_value":470998.43,"total_display":"470,998.43","total_whole":"470,998","shares_owned_after":32546.0,"shares_owned_after_display":"32,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-07","filed_date":"2025-05-09","scope":"insider"},{"id":4860848,"accession":"0001415889-25-008117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-008117","line_url":"/filing/0001415889-25-008117#line-2","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9051.0,"shares_display":"9,051","price_per_share":22.45,"price_display":"22.45","price_state":"stated","total_value":203194.95,"total_display":"203,194.95","total_whole":"203,195","shares_owned_after":26528.0,"shares_owned_after_display":"26,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-14","scope":"insider"},{"id":2757242,"accession":"0001415889-24-027993","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-027993","line_url":"/filing/0001415889-24-027993#line-4","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9.0,"shares_display":"9","price_per_share":22.45,"price_display":"22.45","price_state":"stated","total_value":202.05,"total_display":"202.05","total_whole":"202","shares_owned_after":26528.0,"shares_owned_after_display":"26,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-29","filed_date":"2024-12-02","scope":"insider"},{"id":2757228,"accession":"0001415889-24-027993","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-027993","line_url":"/filing/0001415889-24-027993#line-2","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8637.0,"shares_display":"8,637","price_per_share":22.45,"price_display":"22.45","price_state":"stated","total_value":193900.65,"total_display":"193,900.65","total_whole":"193,901","shares_owned_after":26528.0,"shares_owned_after_display":"26,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-27","filed_date":"2024-12-02","scope":"insider"},{"id":2155352,"accession":"0001415889-24-006170","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-006170","line_url":"/filing/0001415889-24-006170#line-6","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9659.0,"shares_display":"9,659","price_per_share":21.45,"price_display":"21.45","price_state":"stated","total_value":207185.55,"total_display":"207,185.55","total_whole":"207,186","shares_owned_after":17588.0,"shares_owned_after_display":"17,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-01","scope":"insider"},{"id":2155343,"accession":"0001415889-24-006170","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-006170","line_url":"/filing/0001415889-24-006170#line-3","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5126.0,"shares_display":"5,126","price_per_share":21.79,"price_display":"21.79","price_state":"stated","total_value":111695.54,"total_display":"111,695.54","total_whole":"111,696","shares_owned_after":17588.0,"shares_owned_after_display":"17,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-03-01","scope":"insider"},{"id":2804745,"accession":"0001415889-24-000608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-000608","line_url":"/filing/0001415889-24-000608#line-2","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16670.0,"shares_display":"16,670","price_per_share":19.17,"price_display":"19.17","price_state":"stated","total_value":319563.9,"total_display":"319,563.90","total_whole":"319,564","shares_owned_after":17005.0,"shares_owned_after_display":"17,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-02","filed_date":"2024-01-04","scope":"insider"},{"id":7901887,"accession":"0001415889-23-016827","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-016827","line_url":"/filing/0001415889-23-016827#line-2","is_derivative":false,"issuer_cik":"0001464583","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001464583","owner_cik":"0001464583","owner_name":"Megna Michael R","owner_display_name":"Megna Michael R","owner_url":"/insider/0001464583","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9316.0,"shares_display":"9,316","price_per_share":19.13,"price_display":"19.13","price_state":"stated","total_value":178215.08,"total_display":"178,215.08","total_whole":"178,215","shares_owned_after":17005.0,"shares_owned_after_display":"17,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-19","filed_date":"2023-12-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001730430","name":"Kiniksa Pharmaceuticals International, plc","url":"/issuer/0001730430","role":"Officer (CHIEF ACCOUNTING OFFICER)","n_filings":11,"first_seen":"2023-12-21","last_seen":"2026-04-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001464583","retrieved_at":"2026-08-22T11:11:55+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}